SLC1A5 and colorectal carcinoma: Furthermore, our data highlight overexpression of AATs (SLC1A5/ASCT2, SLC7A5/LAT1, and SLC38A2/SNAT2) as prognostic marker of poor survival of patients with CRC (Fig. S7D).